Johnson & Johnson JNJ

$253.28 -0.63 (-0.25%)

Valuation

Market cap
599,124,736,000
Revenue TTM
$94,193,000,000
Net income TTM
$26,804,000,000
PE ratio
24.28
Forward PE
23.79
Profit margin
28.46%
Debt to equity
0.44

Trading

Volume
9,274,516
Avg volume
6,764,354
Day's range
$252.62 – $262.45
Shares out
2,409,898,000
Stochastic %K
45%
Beta
0.21
Analysts
Strong Sell
Price target
$282.76

Price

Company profile

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular...

Show more

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.

Industry
Drug Manufacturers - General
Sector
Healthcare
Phone
732 524 0400
Website
https://www.jnj.com
Address
One Johnson & Johnson Plaza, New Brunswick, United States

Latest news

Stocktwits

tock_strader Oct 15, 9:17 PM
$JNJ I think what he's trying to say is STFU. This experience will be much more enjoyable after muting you
0 replies
cubie Oct 15, 8:47 PM
$COST $JNJ $WMT unh what happened to costco and jnj... oh yea tech pumped $AMD $MU cubie teaches even Scam Street need sell something to buy something ....🫡😏
1 replies
Wallstfan Oct 15, 7:33 PM
$JNJ sold at $162 back in at $252.90. I don’t trust this tech rally
1 replies
Baddb Oct 15, 6:16 PM
$JNJ how am I a crybaby just scalping 😂🤡
0 replies
chursinow62 Oct 15, 6:08 PM
$JNJ Reversal at EOD shorts will get whacked
0 replies
Baddb Oct 15, 6:07 PM
$JNJ 10 million more claimants 😂
1 replies
Baddb Oct 15, 6:06 PM
$JNJ as long as it don’t go deep red I’ll average down gotta bounce soon 😂
0 replies
chursinow62 Oct 15, 5:56 PM
$JNJ big news coming with talc settlement 🚀🚀🚀🚀
0 replies